Difference between revisions of "Part:BBa K2444003"
Line 7: | Line 7: | ||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
+ | |||
+ | Expression data | ||
+ | The lyase-cage-enterocinA fusion protein was produced via cell-free expression system. The expression was verified by SDS gel as shown in the figure below. | ||
+ | https://static.igem.org/mediawiki/2018/5/50/T--Paris_Bettencourt--BBa_2738104.png | ||
+ | 2. MIC and growth curve | ||
+ | We determined the MIC of lyase-cage-enterocinA StarCore to inhibit the growth of E coli and B subtilis (figure A and B). We performed growth curve assay for E coli and B subtilis with and without antimicrobial peptides as shown in figure C and D. | ||
+ | |||
+ | The results indicate that the lyase-cage-enterocinA StarCore has the MIC activity at 150 ug/ml for B subtilis but not for E coli. Moreover, at 7.3 uM it also affects the growth kinetics B. subtilis to a significant extent indicating bactericidal activity. The antibacterial activity of lyase-cage-enterocinA StarCore is comparable to ovispirin at its MIC concentration (5 uM) alone as shown in the figure. | ||
+ | |||
+ | <img scr="https://static.igem.org/mediawiki/2018/a/a9/T--Paris_Bettencourt--BB_104.png"> | ||
+ | |||
+ | Biocompatibility towards mammalian cell membrane | ||
+ | <img scr="https://static.igem.org/mediawiki/2018/2/2d/T--Paris_Bettencourt--liposome_c104.png"> | ||
+ | |||
+ | Figure 2. Mammalian liposome leakage induced by lyase cage-Enterocin A StarCore (A) and the kinetics of liposome leakage (B). Ovispirin (5 uM) and lyase-ovispirin (3.9 uM) are used at their MIC concentration obtained from previous results. | ||
+ | https://static.igem.org/mediawiki/2018/2/2d/T--Paris_Bettencourt--liposome_c104.png | ||
+ | Ovispirin alone lyses the liposome indicating damage to mammalian cell membrane. Lyase-cage-enterocin has a reduced effect on the liposome leakage indicating an improvement in biocompatibility towards mammalian cell membrane. The Starcore ferritin-ovispirin has a safer profile in terms of membrane activity as compared to ovispirin alone at their respective MIC concentration. | ||
+ | |||
+ | References: | ||
+ | Protein lyase cage obtained from RCSB: 4QCC PDB | ||
+ | Enterocin reference from Bactibase: http://bactibase.hammamilab.org/BAC088 | ||
+ | Star shaped antimicrobial peptides : 10.1038/NMICROBIOL.2016.162 | ||
+ | Liposome leakage assay: https://www.sciencedirect.com/science/article/pii/S007668799778025X | ||
+ | |||
<!-- --> | <!-- --> |
Latest revision as of 03:55, 18 October 2018
Codes for the Enterocin A bacteriocin
used to code for Enterocin A bacteriocin, has been modified to express leader peptides originating in Colocin V, optimized for expression in E. coli
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]